BR9909775A - Amida, uso de amidas e preparação farmacêutica - Google Patents
Amida, uso de amidas e preparação farmacêuticaInfo
- Publication number
- BR9909775A BR9909775A BR9909775-3A BR9909775A BR9909775A BR 9909775 A BR9909775 A BR 9909775A BR 9909775 A BR9909775 A BR 9909775A BR 9909775 A BR9909775 A BR 9909775A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- hydrogen
- branched
- unbranched
- amides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Polyamides (AREA)
- Quinoline Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"AMIDA, USO DE AMIDAS E PREPARAçãO FARMACêUTICA". A invenção refere-se a amidas da fórmula geral (I) e às suas formas tautoméricas e isoméricas, as suas possíveis formas enancioméricas e diastereoméricas e possíveis sais fisiologicamente compatíveis, onde as variáveis têm os seguintes significados: R1 é alquila C~ 1~-C~ 6~, fenila, naftila, quinolila, piridila, pirimidila, piridazila, quinazolila e quinoxalila, onde os anéis podem ainda ser substituídos com até 2 radicais R4; R2 é -(CH2)m-R8, onde R8 é fenila, ciclohexila ou indolila e m é 1 a 6; X é uma ligação,-CH2 -, -CH~ 2~CH~ 2~-,-CH=CH -, -C<154>C-, -CONH-, -,-SO~ 2~NH -, e R1-X juntos podem também ser a fórmula (a), R3 é hidrogênio e CO-NR 6 R 7; R4 é hidrogênio, alquila C~ 1~-C~ 4~ ramificada ou não ramificada e O-alquila C~ 1~-C~ 4~; R5 é hidrogênio, alquila C~ 1~-C~ 4~e O-alquila C~ 1~-C~ 4~ ramificada ou não ramificada; R6 é hidrogênio, C~ 1~-C~ 6~ alquila ramificada ou não ramificada; R7 é hidrogênio, alquila C~ 1~-C~ 6~ ramificada ou não ramificada; e n é 0, 1 ou 2. As amidas da fórmula (I) são inibidoras de enzimas, especialmente proteases de cisteína como as calpeínas (proteases de cisteína dependentes de cálcio) e suas isoenzimas e catepsinas, tais como B e L.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19818614A DE19818614A1 (de) | 1998-04-20 | 1998-04-20 | Neue substituierte Amide, deren Herstellung und Anwendung |
| PCT/EP1999/002618 WO1999054294A1 (de) | 1998-04-20 | 1999-04-19 | Neue substituierte amide, deren herstellung und anwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9909775A true BR9909775A (pt) | 2000-12-19 |
Family
ID=7865830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9909775-3A BR9909775A (pt) | 1998-04-20 | 1999-04-19 | Amida, uso de amidas e preparação farmacêutica |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6448254B1 (pt) |
| EP (1) | EP1073631A1 (pt) |
| JP (1) | JP2002512221A (pt) |
| KR (1) | KR20010042836A (pt) |
| CN (1) | CN1297432A (pt) |
| AU (1) | AU753402B2 (pt) |
| BG (1) | BG104855A (pt) |
| BR (1) | BR9909775A (pt) |
| CA (1) | CA2328435A1 (pt) |
| DE (1) | DE19818614A1 (pt) |
| HR (1) | HRP20000776A2 (pt) |
| HU (1) | HUP0101624A3 (pt) |
| ID (1) | ID26402A (pt) |
| IL (1) | IL138412A0 (pt) |
| NO (1) | NO20005266D0 (pt) |
| PL (1) | PL343465A1 (pt) |
| SK (1) | SK13942000A3 (pt) |
| TR (1) | TR200003028T2 (pt) |
| WO (1) | WO1999054294A1 (pt) |
| ZA (1) | ZA200006711B (pt) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6683581B2 (en) * | 2000-12-29 | 2004-01-27 | Bellsouth Intellectual Property Corporation | Antenna alignment devices |
| US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| DE10114762A1 (de) * | 2001-03-26 | 2002-10-02 | Knoll Gmbh | Verwendung von Cysteinprotease-Inhibitoren |
| US20050107616A1 (en) * | 2001-08-03 | 2005-05-19 | David Gene Barrett | Alpha-ketoamide derivatives as cathepsin k inhibitors |
| EP1465862A1 (en) | 2002-01-17 | 2004-10-13 | SmithKline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| CA2505098A1 (en) | 2002-11-12 | 2004-05-27 | Merck & Co., Inc. | Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| GB0228410D0 (en) | 2002-12-05 | 2003-01-08 | Glaxo Group Ltd | Novel Compounds |
| EP1700850B1 (en) * | 2003-12-22 | 2015-07-15 | Ajinomoto Co., Inc. | Phenylalanine derivative |
| MX2007000095A (es) | 2004-06-24 | 2007-03-21 | Vertex Pharma | Moduladores de transportadores con casete de union con atp. |
| US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| CA2634113A1 (en) * | 2005-12-24 | 2007-07-05 | Vertex Pharmaceuticals Incorporated | Quinolin- 4 - one derivatives as modulators of abc transporters |
| SI3219705T1 (sl) | 2005-12-28 | 2020-08-31 | Vertex Pharmaceuticals Incorporated | Farmacevtski sestavki amorfne oblike N-(2,4-bis(1,1-dimetiletil)-5- hidroksifenil)-1,4-dihidro-4-oksokinolin-3-karboksamid |
| AR064693A1 (es) | 2006-12-29 | 2009-04-22 | Abbott Gmbh & Co Kg | Compuestos carboxamidas y su utilizacion en la elaboracion de un medicamento para el tratamiento de enfermedades asociadas a alta actividad de calpaina. |
| TWI453019B (zh) | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
| DE102008027133A1 (de) | 2008-05-30 | 2009-12-03 | Ls Medcap Gmbh | Vollsynthetisches Albumin-Analogon |
| TWI519530B (zh) | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途 |
| LT2821400T (lt) | 2009-03-20 | 2018-02-12 | Vertex Pharmaceuticals Incorporated | Cistinės fibrozės transmembraninio laidumo reguliatoriaus moduliatorių gamybos būdas |
| US8236798B2 (en) | 2009-05-07 | 2012-08-07 | Abbott Gmbh & Co. Kg | Carboxamide compounds and their use as calpain inhibitors |
| US9051304B2 (en) | 2009-12-22 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
| US8598211B2 (en) * | 2009-12-22 | 2013-12-03 | Abbvie Inc. | Carboxamide compounds and their use as calpain inhibitors IV |
| CN103501784A (zh) | 2010-12-09 | 2014-01-08 | Abbvie德国有限责任两合公司 | 甲酰胺化合物及它们作为钙蛋白酶抑制剂v的用途 |
| US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| RU2692779C2 (ru) | 2012-02-27 | 2019-06-27 | Вертекс Фармасьютикалз Инкорпорейтед | Фармацевтическая композиция и ее введения |
| MX2014011998A (es) | 2012-04-03 | 2015-05-11 | Abbvie Deutschland | Compuestos carboxamida y su uso como inhibidores de calpaína v. |
| EP3204358B1 (en) | 2014-10-07 | 2018-09-19 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
| WO2017156071A1 (en) | 2016-03-09 | 2017-09-14 | Blade Therapeutics, Inc. | Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof |
| AU2017292646A1 (en) | 2016-07-05 | 2019-02-07 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| CN110023304A (zh) | 2016-09-28 | 2019-07-16 | 布莱德治疗公司 | 钙蛋白酶调节剂及其治疗用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5289954A (en) | 1990-01-05 | 1994-03-01 | Steag Aktiengesellschaft | Device for metered removal of flowable solid material |
| DE4000204A1 (de) | 1990-01-05 | 1991-07-11 | Steag Ag | Vorrichtung zum dosierten austragen von schuettfaehigem feststoff |
| WO1992012140A1 (en) | 1990-12-28 | 1992-07-23 | Georgia Tech Research Corporation | Peptides ketoamides, ketoacids, and ketoesters |
| AU667463B2 (en) | 1990-12-28 | 1996-03-28 | Cortex Pharmaceuticals, Inc. | Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| CA2071621C (en) | 1991-06-19 | 1996-08-06 | Ahihiko Hosoda | Aldehyde derivatives |
| CA2138124A1 (en) | 1992-06-24 | 1994-01-06 | David D. Eveleth, Jr. | Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| JP2848232B2 (ja) * | 1993-02-19 | 1999-01-20 | 武田薬品工業株式会社 | アルデヒド誘導体 |
| US5674889A (en) | 1993-02-22 | 1997-10-07 | Merck, Sharp & Dohme, Ltd. | Aromatic compounds, compositions containing them and their use in therapy |
| US5541290A (en) | 1993-06-24 | 1996-07-30 | Harbeson; Scott L. | Optically pure calpain inhibitor compounds |
| WO1996039194A1 (en) | 1995-06-06 | 1996-12-12 | Athena Neurosciences, Inc. | Novel cathepsin and methods and compositions for inhibition thereof |
| AU6977096A (en) | 1995-09-14 | 1997-04-01 | Cephalon, Inc. | Ketomethylene group-containing cysteine and serine protease inhibitors |
| CA2238175A1 (en) | 1995-11-28 | 1997-06-19 | Cephalon, Inc. | D-amino acid derived inhibitors of cysteine and serine proteases |
-
1998
- 1998-04-20 DE DE19818614A patent/DE19818614A1/de not_active Withdrawn
-
1999
- 1999-04-19 HU HU0101624A patent/HUP0101624A3/hu unknown
- 1999-04-19 JP JP2000544635A patent/JP2002512221A/ja active Pending
- 1999-04-19 ID IDW20002112A patent/ID26402A/id unknown
- 1999-04-19 PL PL99343465A patent/PL343465A1/xx not_active Application Discontinuation
- 1999-04-19 KR KR1020007011600A patent/KR20010042836A/ko not_active Application Discontinuation
- 1999-04-19 TR TR2000/03028T patent/TR200003028T2/xx unknown
- 1999-04-19 WO PCT/EP1999/002618 patent/WO1999054294A1/de not_active Application Discontinuation
- 1999-04-19 SK SK1394-2000A patent/SK13942000A3/sk unknown
- 1999-04-19 CA CA002328435A patent/CA2328435A1/en not_active Abandoned
- 1999-04-19 BR BR9909775-3A patent/BR9909775A/pt not_active IP Right Cessation
- 1999-04-19 EP EP99917996A patent/EP1073631A1/de not_active Withdrawn
- 1999-04-19 IL IL13841299A patent/IL138412A0/xx unknown
- 1999-04-19 CN CN99805245A patent/CN1297432A/zh active Pending
- 1999-04-19 AU AU36071/99A patent/AU753402B2/en not_active Ceased
- 1999-04-19 US US09/647,677 patent/US6448254B1/en not_active Expired - Fee Related
-
2000
- 2000-10-13 BG BG104855A patent/BG104855A/xx unknown
- 2000-10-19 NO NO20005266A patent/NO20005266D0/no not_active Application Discontinuation
- 2000-11-15 HR HR20000776A patent/HRP20000776A2/hr not_active Application Discontinuation
- 2000-11-17 ZA ZA200006711A patent/ZA200006711B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002512221A (ja) | 2002-04-23 |
| KR20010042836A (ko) | 2001-05-25 |
| AU753402B2 (en) | 2002-10-17 |
| TR200003028T2 (tr) | 2001-01-22 |
| HRP20000776A2 (en) | 2001-06-30 |
| PL343465A1 (en) | 2001-08-13 |
| IL138412A0 (en) | 2001-10-31 |
| CN1297432A (zh) | 2001-05-30 |
| NO20005266L (no) | 2000-10-19 |
| SK13942000A3 (sk) | 2001-05-10 |
| AU3607199A (en) | 1999-11-08 |
| BG104855A (en) | 2001-05-31 |
| NO20005266D0 (no) | 2000-10-19 |
| DE19818614A1 (de) | 1999-10-21 |
| EP1073631A1 (de) | 2001-02-07 |
| ZA200006711B (en) | 2002-01-09 |
| WO1999054294A1 (de) | 1999-10-28 |
| CA2328435A1 (en) | 1999-10-28 |
| HUP0101624A2 (hu) | 2001-11-28 |
| ID26402A (id) | 2000-12-21 |
| US6448254B1 (en) | 2002-09-10 |
| HUP0101624A3 (en) | 2003-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9909775A (pt) | Amida, uso de amidas e preparação farmacêutica | |
| DK1019368T3 (da) | Acylsulfamoylbenzoesyreamider, nytteplantebeskyttelsesmidler indeholdende disse samt fremgangsmåder til deres fremstilling | |
| DE69634045D1 (de) | Antithrombotische diamine | |
| ATE396993T1 (de) | Tetrahydropyranyl-cyclopentyl- tetrahydropyridopyridin-modulatoren der chemokin- rezeptor-aktivität | |
| EA200100972A1 (ru) | Новые соединения и композиции как ингибиторы протеаз | |
| DE69911980D1 (de) | Pyrimidinonderivate zur behandlung von atheroscleros | |
| HUP0302962A2 (hu) | Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása | |
| ECSP034524A (es) | Derivados de pirina con actividad inhibidora de quinasa ikb (ikk-beta) | |
| ME00090B (me) | Jedinjenja koja sadrže laktam i njihovi derivati kao inhibitori faktora xa | |
| EA200000920A1 (ru) | Производные бициклических гидроксамовых кислот | |
| EA200400815A1 (ru) | Контролируемый синтез зипразидона и его композиции | |
| PT1007523E (pt) | Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao | |
| EA200200253A1 (ru) | Ингибиторы клеточной адгезии | |
| HUP0001309A2 (hu) | 1-Fenil-4-benzil-piperazinok és a vegyületeket tartalmazó gyógyászati készítmények | |
| TR199802536T2 (xx) | Yeni amino asit t�revleri,trombin inhibit�rleri olarak kullan�lmalar�. | |
| YU41198A (sh) | Derivati pirolopirolona kao inhibitori neutrofilne elastaze | |
| NZ334906A (en) | A sulphonamido pentanoic acid derivative useful as an interleukin-1-beta converting enzyme inhibitor | |
| HUP0402244A2 (hu) | Heterociklusos glicinamid-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0301587A2 (hu) | Foszfodiészteráz V gátló hatású 5-amino-alkil-pirazolo[4,3-d]pirimidinek, ezeket tartalmazó gyógyszerkészítmények és eljárások az elżállításaikra | |
| HUP0201910A2 (hu) | Új aminobenzofenonszármazékok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| EA200100297A1 (ru) | Моногидрат гидробромида элетриптана | |
| BR0107823A (pt) | Processo para a obtenção de ácido fórmico anidro ou substancialmente anidro, uso de uma carboxamida, e, aparelho para realizar um processo | |
| EA200200807A1 (ru) | Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece | |
| MY130750A (en) | Pyrimidine derivatives useful as selective cox-2 inhibitors | |
| HUP9902316A2 (hu) | Endotelin-antagonista hatású 4-(benzo-1,3-dioxolil)-pirrolidin-3-karbonsav-származékok és az ezeket tartalmazó gyógyszerkészítmények |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5O,6O, 7O E 8O ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |